BCG-UNRESPONSIVE BLADDER CANCER
Clinical trials for BCG-UNRESPONSIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new BCG-UNRESPONSIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for BCG-UNRESPONSIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Two-Drug bladder wash beat cancer recurrence?
Disease control Recruiting nowThis trial tests two different drug combinations given directly into the bladder for people with a type of bladder cancer that has not responded to the standard BCG therapy. Participants are randomly assigned to receive either gemcitabine plus docetaxel or gemcitabine plus mitomy…
Matched conditions: BCG-UNRESPONSIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Bladder cancer patients may avoid surgery with new drug combo
Disease control Recruiting nowThis phase 2 trial is testing whether two chemotherapy drugs, gemcitabine and docetaxel, given directly into the bladder can treat high-risk bladder cancer that did not respond to standard BCG therapy. About 174 adults will receive weekly treatments for 6 weeks, then monthly for …
Matched conditions: BCG-UNRESPONSIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC